Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

L-PHENYLALANINE METHYL ESTER HYDROCHLORIDE PME REA

K-Number: K874328 · 1988-02-16

ApplicantE.I. Dupont DE Nemours & Co., Inc.
Decision Date1988-02-16
Product CodeJCF
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

L-PHENYLALANINE METHYL ESTER HYDROCHLORIDE PME REA is the device name listed in this FDA 510(k) record. The listed applicant is E.I. Dupont DE Nemours & Co., Inc.. It received FDA 510(k) clearance on 1988-02-16 under 510(k) number K874328. The device is classified under product code JCF. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the L-PHENYLALANINE METHYL ESTER HYDROCHLORIDE PME REA?

L-PHENYLALANINE METHYL ESTER HYDROCHLORIDE PME REA is a medical device that received FDA 510(k) clearance on 1988-02-16. The listed applicant is E.I. Dupont DE Nemours & Co., Inc.. The 510(k) number is K874328.

When did L-PHENYLALANINE METHYL ESTER HYDROCHLORIDE PME REA receive FDA 510(k) clearance?

L-PHENYLALANINE METHYL ESTER HYDROCHLORIDE PME REA received FDA 510(k) clearance on 1988-02-16, under 510(k) number K874328.

Who is the listed applicant for L-PHENYLALANINE METHYL ESTER HYDROCHLORIDE PME REA?

The FDA 510(k) record lists E.I. Dupont DE Nemours & Co., Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for L-PHENYLALANINE METHYL ESTER HYDROCHLORIDE PME REA?

The FDA product code for L-PHENYLALANINE METHYL ESTER HYDROCHLORIDE PME REA is JCF.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing E.I. Dupont DE Nemours & Co., Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K951851ALLIANCE CYTOMEGALOVIRUS IMMEDIATE EARLY ANTIGEN DIRECT IMMUNOFLUORESCENCE ASSAYK953724CRONEX RADIATION THERAPY CASSETTEK953725CRONEX RADIATION THERAPY VERIFICATION CASSETTEK951441DUPONT ACA DIGOXIN (DGN A) METHODK950137URINE BARBITURATES SCREEN FLEX(TM) REAGENT CARTRIDGEK950136URINE OPIATES SCREEN FLEX(TM) REAGENT CARTRIDGE

View all 253 devices →

Related Devices (Code: JCF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K911731LEUCOPREP(R) BRAND CELL SEPARAT TUBE W/SODIUM CITRBd Becton Dickinson Vacutainer Systems PreanalyticK902445LYMPHO SEP(TM)Icn Biomedicals, Inc.K891407LEUCOPREP CELL SEPARATION TUBEBd Becton Dickinson Vacutainer Systems PreanalyticK873185DYNABEADS HLA CELL PREP II ISOLATION PRODUCTDynal Biotech, Inc.K872775LEUCOPREP BRAND TUBEBd Becton Dickinson Vacutainer Systems PreanalyticK860354SEPRACELL LYMPHOCYTE SEPARATION MEDIUMSepratech Corporation C/O Keller and Heckman

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑